Verrica Pharmaceuticals Stock Today
| VRCA Stock | USD 6.90 0.16 2.27% |
Performance7 of 100
| Odds Of DistressOver 75
|
Verrica Pharmaceuticals is trading at 6.90 as of the 19th of April 2024, a -2.27 percent decrease since the beginning of the trading day. The stock's open price was 7.06. Verrica Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Verrica Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2023 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of June 2018 | Category Healthcare | Classification Health Care |
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. The company has 42.42 M outstanding shares of which 4.18 M shares are at this time shorted by private and institutional investors with about 32.35 trading days to cover. More on Verrica Pharmaceuticals
Moving against Verrica Stock
| 0.75 | VERV | Verve Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.66 | VAXX | Vaxxinity Financial Report 14th of May 2024 | PairCorr |
| 0.59 | VCNX | Vaccinex | PairCorr |
| 0.56 | DMAC | DiaMedica Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.44 | VINC | Vincerx Pharma Financial Report 9th of May 2024 | PairCorr |
| 0.42 | DRRX | Durect Financial Report 13th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Verrica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Verrica Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Verrica Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Ted White | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Verrica Pharmaceuticals report their recommendations after researching Verrica Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Verrica Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Verrica Pharmaceuticals. The Verrica consensus assessment is calculated by taking the average forecast from all of the analysts covering Verrica Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Verrica Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Verrica Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Verrica Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Verrica Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Verrica Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Verrica Pharmaceuticals' financial leverage. It provides some insight into what part of Verrica Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Verrica Pharmaceuticals (VRCA) is traded on NASDAQ Exchange in USA. It is located in 44 West Gay Street, West Chester, PA, United States, 19380 and employs 100 people. Verrica Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 292.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Verrica Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Verrica Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Verrica Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 42.42 M outstanding shares of which 4.18 M shares are at this time shorted by private and institutional investors with about 32.35 trading days to cover.
Verrica Pharmaceuticals currently holds about 14.4 M in cash with (38.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Check Verrica Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationVerrica Pharmaceuticals maintains a total of 42.42 Million outstanding shares. Verrica Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Verrica Ownership Details
Verrica Stock Price Odds Analysis
What are Verrica Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Verrica Pharmaceuticals jumping above the current price in 90 days from now is under 4%. The Verrica Pharmaceuticals probability density function shows the probability of Verrica Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.0961. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Verrica Pharmaceuticals will likely underperform. Additionally, verrica Pharmaceuticals has an alpha of 0.2509, implying that it can generate a 0.25 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Verrica Pharmaceuticals to move above the current price in 90 days from now is under 4 (This Verrica Pharmaceuticals probability density function shows the probability of Verrica Stock to fall within a particular range of prices over 90 days) .
Verrica Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Verrica Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Verrica Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Verrica Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Miracle Mile Advisors, Inc. | 2023-12-31 | 118.2 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 111.3 K | |
| J. Goldman & Co Lp | 2023-12-31 | 108 K | |
| Bridgeway Capital Management, Llc | 2023-12-31 | 106.8 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 95 K | |
| Deutsche Bank Ag | 2023-12-31 | 85.6 K | |
| Kornitzer Capital Management Inc | 2023-12-31 | 74.3 K | |
| Balyasny Asset Management Llc | 2023-12-31 | 65.3 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 55.7 K | |
| Perceptive Advisors Llc | 2023-12-31 | 7.1 M | |
| Venbio Select Advisor Llc | 2023-12-31 | 4 M |
Verrica Pharmaceuticals Historical Income Statement
Verrica Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Verrica's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Verrica Pharmaceuticals revenue and expense. Verrica Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Verrica Pharmaceuticals' Net Interest Income is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.2 M, whereas Selling General Administrative is forecasted to decline to about 17.5 M. View More FundamentalsVerrica Stock Against Markets
Picking the right benchmark for Verrica Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Verrica Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Verrica Pharmaceuticals is critical whether you are bullish or bearish towards Verrica Pharmaceuticals at a given time. Please also check how Verrica Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Verrica Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Verrica Pharmaceuticals Corporate Directors
Verrica Pharmaceuticals corporate directors refer to members of a Verrica Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Verrica Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Verrica Pharmaceuticals' board members must vote for the resolution. The Verrica Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jayson Rieger | Director | Profile | |
| Sean Stalfort | Director | Profile | |
| Glenn Oclassen | Independent Director | Profile | |
| Craig Ballaron | Director | Profile |
How to buy Verrica Stock?
Before investing in Verrica Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Verrica Pharmaceuticals. To buy Verrica Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Verrica Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Verrica Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Verrica Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Verrica Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Verrica Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Verrica Stock please use our How to Invest in Verrica Pharmaceuticals guide.
Already Invested in Verrica Pharmaceuticals?
The danger of trading Verrica Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Verrica Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Verrica Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Verrica Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Verrica Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verrica Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verrica Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verrica Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.Note that the Verrica Pharmaceuticals information on this page should be used as a complementary analysis to other Verrica Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Verrica Stock analysis
When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Verrica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.113 | Quarterly Revenue Growth 28.235 | Return On Assets (0.63) | Return On Equity (2.24) |
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.